Published

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: JAMA Psychiatry
Date: 2026-05-01
Source: Crossref
DOI: 10.1001/jamapsychiatry.2026.0132
PubMed: 41848690

Derived topics and classifications

psilocybin Depression Clinical Trial Treatment-Resistant Depression Safety Adverse Events Clinical Trial

Citation graph

35 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

10.1016/s0140-6736(24)00757-8 10.1001/jamapsychiatry.2022.3860 10.1186/s12888-019-2222-4 10.1016/s2215-0366(16)30065-7 10.1016/j.medj.2024.01.005 10.1001/jamapsychiatry.2020.3285 10.1016/j.eclinm.2022.101809 10.1001/jama.2023.14530 10.1056/nejmoa2206443 10.1056/nejmoa2032994 10.1136/bmj-2023-078084 10.1016/j.nsa.2022.100104

Indexed papers citing this DOI

Cardiovascular safety of psilocybin in psychiatric practice: a narrative review2026-08-01 PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW2026-06-24 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 Enlightenment in a Pill-Testing the Efficacy of Psilocybin2026-05-01

Related papers

Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01 A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Journal of clinical psychopharmacology · 2022-01-01 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08 Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin.American journal of therapeutics · 2024-01-01 The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2022-01-01 The Potential of Psilocybin Administration in Terminal Cancer PatientsOncology Times · 2019-06-28 Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.Psychiatry research · 2025-02-01